FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann ZURICH (Reuters) – The U.S. Food and Drug Administration has granted priority review for Novartis... More »
Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and Mekinist to treat patients with BRAF V600-positive stage III melanoma following surgery. More »
By Andrew M. SeamanMelanoma survivors may want to enlist partners to help search their bodies for suspicious looking moles, according to new researc More »
We use cookies!
By using this site you agree to the use of cookies, more info.
